- Report ID : MD1219 |
- Pages : 185 |
- Tables : 95 |
- Formats :
By Type (animal primary cells and human primary cells), By Origin (gastrointestinal, skin, blood, renal, hepatocytes, hematopoietic and skeleton and muscles), By End Use (research institutes and life science research), By Region(North America, Europe, APAC and Rest of the World)
Human Primary cell market revenue is estimated to be $XX Billion in 2018 and shall grow with a CAGR of XX.X% during the forecast period of 2019 to 2026.
Growing problems related to cancer worldwide are one of the leading drivers of the market. The other major factors that are increasing market growth are the increase in the funding of treatment technology to provide better treatment to the people. Apart from this, the growing interest of youth in the field of research is also contributing to the development of human primary cells. Apart from this, improvement in cancer treatment techniques and acquisitions and collaboration is expected to increase market revenue significantly. The ongoing technological progress and innovation in research and medical technology are driving forward the growth of the market substantially.
The trend of study of the drug for stem interaction and stem cells in the youth is increasing, and in the last few years, the education sector is making significant contributions to the market revenues of human primary cells. However, the cost of advanced human elementary cells is slightly higher, which could disrupt the industry growth. Besides, increasing concerns about the contamination of human primary cells can limit the market of human primary cells in the future. Besides, progressive biomedical research using primary cells in 3D culture is likely to provide new growth opportunities for the human elementary cells market.
High demand for human primary cells in the Research companies and educational institutions to increase the market revenue:
The North America region is the dominant region in contributing to the market growth in 2018. The rising influence of cancer-related diseases is driving the industry shares in North America. Further, the U.Sregion is anticipated to fuel up the market revenue significantly over the forecast period owing to rising concerns of the government regarding the serious diseases of the region. Moreover, the Asia Pacific region is also anticipated to grow significantly over the forecast period owing to the rising investment in the market in the region. The developing countries such as India, Japan, and China have contributed significantly to propelling the market shares as there is a high prevalence of cancer diseases in these areas. Further, the growth of this industry is also enhanced by the Educational Institutions and Research Companies significantly.
Life science research industries are likely to show its dominance over the market revenue:
Based on the software type, the segmentation has been done as animal primary cells and human primary cells. By origin, the segmentation has been done as gastrointestinal, skin, blood, renal, hepatocytes, hematopoietic and skeleton and muscles. By end use, the market has been bifurcated as research institutes and life science research. Out of which, the life science research industry is anticipated to augment the shares of the market significantly over the forecast period. Rising standards of the medical infrastructure across the world and strictly implemented rules are going to support the market growth in the coming years.
Human Primary cells Companies:
Major industry players have been analyzed with coverage on their operating areas, revenues, and other strategic aspects. These industry players include Thermo Fisher Scientific, Merck KGaA, PromoCell, ZenBio, Lonza, Cell Biologics, STEMCELL Technologies, Axol Biosciences, AllCells, and American Type Culture Collection. Many industry players are adopting smart technologies and strategies to expand their business all over the world.
Key Points covered in the Report:
• Revenue Estimation and Forecast (2018 – 2026)
• Production Estimation and Forecast (2018 – 2026)
• Breakdown of Revenue by Segments (2018 – 2026)
• Breakdown of Production by Segments (2018 – 2026)
• Gross Margin and Profitability Analysis of Companies
• Business Trend and Expansion Analysis
• Import and Export Analysis
• Regional Analysis and Data Breakdown
MARKET SEGMENTATION
By Type Outlook ($Revenue, 2018-2026)
• Animal primary cells
• Human primary cells
ByOriginOutlook ($Revenue, 2018-2026)
• Gastrointestinal
• Skin
• Blood
• Renal
• Hepatocytes
• Hematopoietic
• Skeleton and muscles
ByEnd useOutlook ($Revenue, 2018-2026)
• Research institutes
• Life science research
By Regional Outlook ($Revenue, 2018-2026)
• North America
• Canada
• U.S
• Mexico
• Europe
• Germany
• France
• U.K
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Rest of Asia Pacific
• Rest of the World
• Middle East & Africa
• Latin America
Human Primary cells Companies:
• Thermo Fisher Scientific
• Merck KGaA
• PromoCell
• ZenBio
• Lonza
• Cell Biologics
• STEMCELL Technologies
• Axol Biosciences
• AllCells
• American Type Culture Collection
CHAPTER 1: INTRODUCTION
1.1. Research Methodology
1.1.1. Desk Research
1.1.2. Data Synthesis
1.1.3. Data Validation & Market Feedback
1.1.4. Data Sources
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Global Market Outlook
2.2. Core Insights - Type
2.3. Core Insights – Origin
2.4. Core Insights – End Use
2.5. Core Insights – Geography
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Forces Shaping the Industry
3.2.1. Bargaining Power of Suppliers
3.2.2. Bargaining Power of Buyers
3.2.3. Threat of Substitutes
3.2.4. Threat of New Entrants
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Supply-side Drivers
3.3.1.2. Demand-side Drivers
3.3.2. Restraints
3.3.3. Opportunities
3.4. Industry Landscape - PESTEL Analysis
3.4.1. Political Landscape
3.4.2. Environmental Landscape
3.4.3. Social Landscape
3.4.4. Technology Landscape
3.4.5. Economic Landscape
CHAPTER 4: MARKET BACKGROUND
4.1. Industry Value Chain Analysis
4.1.1. Upstream Participants
4.1.2. Downstream participants
4.2. Pricing Analysis and Forecast, 2018-2026
4.2.1. By Type
4.2.2. By Region
CHAPTER 5: GLOBAL HUMAN PRIMARY CELLS MARKET, BY TYPE
5.1. Overview
5.1.1. Market Volume and Forecast, 2018-2026
5.1.2. Market Revenue (US$ Million) and Forecast, 2018-2026
5.2. Animal primary cells
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Volume and Forecast, By Region
5.2.3. Market Revenue (US$ Million) and Forecast, By Region
5.3. Human primary cells
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Volume and Forecast, By Region
5.3.3. Market Revenue (US$ Million) and Forecast, By Region
CHAPTER 6: GLOBAL HUMAN PRIMARY CELLS MARKET, BY ORIGIN
6.1. Overview
6.1.1. Market Volume and Forecast, 2018-2026
6.1.2. Market Revenue (US$ Million) and Forecast, 2018-2026
6.2. Gastrointestinal
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Volume and Forecast, By Region
6.2.3. Market Revenue (US$ Million) and Forecast, By Region
6.3. Skin
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Volume and Forecast, By Region
6.3.3. Market Revenue (US$ Million) and Forecast, By Region
6.4. Blood
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Volume and Forecast, By Region
6.4.3. Market Revenue (US$ Million) and Forecast, By Region
6.5. Renal
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Volume and Forecast, By Region
6.5.3. Market Revenue (US$ Million) and Forecast, By Region
6.6. Hepatocytes
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Volume and Forecast, By Region
6.6.3. Market Revenue (US$ Million) and Forecast, By Region
6.7. Hematopoietic
6.7.1. Key Market Trends, Growth Factors and Opportunities
6.7.2. Market Volume and Forecast, By Region
6.7.3. Market Revenue (US$ Million) and Forecast, By Region
6.8. Skeleton and muscles
6.8.1. Key Market Trends, Growth Factors and Opportunities
6.8.2. Market Volume and Forecast, By Region
6.8.3. Market Revenue (US$ Million) and Forecast, By Region
CHAPTER 7: GLOBAL HUMAN PRIMARY CELLS MARKET, BY END USE
7.1. Overview
7.1.1. Market Volume and Forecast, 2018-2026
7.1.2. Market Revenue (US$ Million) and Forecast, 2018-2026
7.2. Research institutes
7.2.1. Key Market Trends, Growth Factors and Opportunities
7.2.2. Market Volume and Forecast, By Region
7.2.3. Market Revenue (US$ Million) and Forecast, By Region
7.3. Life science research
7.3.1. Key Market Trends, Growth Factors and Opportunities
7.3.2. Market Volume and Forecast, By Region
7.3.3. Market Revenue (US$ Million) and Forecast, By Region
CHAPTER 8: GLOBAL HUMAN PRIMARY CELLS MARKET, BY GEOGRAPHY
8.1. Overview
8.2. North America
8.2.1. Key Market Trends, Growth Factors and Opportunities
8.2.2. Market Volume and Forecast, By Type
8.2.3. Market Volume and Forecast, By Origin
8.2.4. Market Volume and Forecast, By End Use
8.2.5. Market Revenue and Forecast, By Type
8.2.6. Market Revenue and Forecast, By Origin
8.2.7. Market Revenue and Forecast, By End Use
8.2.8. Market Revenue and Forecast, By Country
8.2.9. U.S.
8.2.9.1. Market Volume and Forecast
8.2.9.2. Market Revenue and Forecast
8.2.10. Canada
8.2.10.1. Market Volume and Forecast
8.2.10.2. Market Revenue and Forecast
8.2.11. Mexico
8.2.11.1. Market Volume and Forecast
8.2.11.2. Market Revenue and Forecast
8.3. Europe
8.3.1. Market Volume and Forecast, By Type
8.3.2. Market Volume and Forecast, By Origin
8.3.3. Market Volume and Forecast, By End Use
8.3.4. Market Revenue and Forecast, By Type
8.3.5. Market Revenue and Forecast, By Origin
8.3.6. Market Revenue and Forecast, By End Use
8.3.7. Market Revenue and Forecast, By Country
8.3.8. Germany
8.3.8.1. Market Volume and Forecast, By Type
8.3.8.2. Market Revenue and Forecast, By Origin
8.3.9. UK
8.3.9.1. Market Volume and Forecast, By Type
8.3.9.2. Market Revenue and Forecast, By Origin
8.3.10. France
8.3.10.1. Market Volume and Forecast, By Type
8.3.10.2. Market Revenue and Forecast, By Origin
8.3.11. Italy
8.3.11.1. Market Volume and Forecast, By Type
8.3.11.2. Market Revenue and Forecast, By Origin
8.3.12. Rest of Europe
8.3.12.1. Market Volume and Forecast, By Type
8.3.12.2. Market Revenue and Forecast, By Origin
8.4. Asia-Pacific
8.4.1. Market Volume and Forecast, By Type
8.4.2. Market Volume and Forecast, By Origin
8.4.3. Market Volume and Forecast, By End Use
8.4.4. Market Revenue and Forecast, By Type
8.4.5. Market Revenue and Forecast, By Origin
8.4.6. Market Revenue and Forecast, By End Use
8.4.7. Market Revenue and Forecast, By Country
8.4.8. China
8.4.8.1. Market Volume and Forecast, By Type
8.4.8.2. Market Revenue and Forecast, By Origin
8.4.9. India
8.4.9.1. Market Volume and Forecast, By Type
8.4.9.2. Market Revenue and Forecast, By Origin
8.4.10. Japan
8.4.10.1. Market Volume and Forecast, By Type
8.4.10.2. Market Revenue and Forecast, By Origin
8.4.11. South Korea
8.4.11.1. Market Volume and Forecast, By Type
8.4.11.2. Market Revenue and Forecast, By Origin
8.4.12. Rest of Asia-Pacific
8.4.12.1. Market Volume and Forecast, By Type
8.4.12.2. Market Revenue and Forecast, By Origin
8.5. REST OF THE WORLD
8.5.1. Market Volume and Forecast, By Type
8.5.2. Market Volume and Forecast, By Origin
8.5.3. Market Volume and Forecast, By End Use
8.5.4. Market Revenue and Forecast, By Type
8.5.5. Market Revenue and Forecast, By Origin
8.5.6. Market Revenue and Forecast, By End Use
8.5.7. Market Revenue and Forecast, By Country
8.5.8. Latin America
8.5.8.1. Market Volume and Forecast, By Type
8.5.8.2. Market Revenue and Forecast, By Origin
8.5.9. Middle East
8.5.9.1. Market Volume and Forecast, By Type
8.5.9.2. Market Revenue and Forecast, By Origin
8.5.10. Africa
8.5.10.1. Market Volume and Forecast, By Type
8.5.10.2. Market Revenue and Forecast, By Origin
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Human Primary Cells Market Share Analysis, 2018
CHAPTER 10: COMPANY PROFILES
10.1. Thermo Fisher Scientific
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. SWOT Analysis
10.2. Merck KGaA
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. SWOT Analysis
10.3. PromoCell
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. SWOT Analysis
10.4. ZenBio
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. SWOT Analysis
10.5. Lonza
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. SWOT Analysis
10.6. Cell Biologics
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. SWOT Analysis
10.7. STEMCELL Technologies
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. SWOT Analysis
10.8. Axol Biosciences
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. SWOT Analysis
10.9. AllCells
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. SWOT Analysis
10.10. American Type Culture Collection
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. SWOT Analysis
20% Free Customization ON ALL PURCHASE
*Terms & Conditions Apply
Please fill in the form below to Request for free Sample Report
Office Hours Mon - Sat 10:00 - 16:00
Send Us Mail sales@marketdecipher.com
Market Decipher is a market research and consultancy firm involved in provision of market reports to organisations of varied sizes; small, large and medium.
© 2018 Market Decipher. All Rights Reserved
